The VAT reduction does not automatically reverse when the peptide is discontinued, provided eating, training, and sleep patterns are maintained
Increased lean body mass: while not a muscle-building peptide in the traditional sense, tesamorelins effect on GH levels supports lean mass preservation, which is clinically significant for patients over 50
The choice between semaglutide and tirzepatide depends on factors like efficacy preferences, side effect profiles , insurance coverage, and provider recommendation rather than BMI differences
[1] Because visceral adiposity is itself linked to cardiometabolic risk, these lipid changes are biologically coherent
Dempsey reported that many of her patients with gut motility issues are doing well on the low doses of the drug being used, and a mast cell paper reported that reductions in nausea were common